Alzheimer Disease and Dementia
Medicare Coverage of Aducanumab for Alzheimer Disease: The Impact of the Decision
- Expansion of Telehealth, OUD Medication Access During Pandemic Raised Retention
- Long-Term Lithium Exposure May Damage Kidney Function
- Veterans With IBS Experience Psychological Comorbidities, High Health Care Use
- Depression, Anxiety Reduce Likelihood of Achieving Minimal Disease Activity in Psoriatic Arthritis
- Air Pollution Associated With Autism-Related Hospital Admissions in Children
- Sleep Problems Associated With Increased Risk for Cognitive Decline, Dementia
- Treatment Benefits Adults With Major Depression, With or Without Childhood Trauma
- Healthy Lifestyle Can Further Lower Risk for Death in Former Smokers
- Propranolol Shows Potential as Pharmacokinetic Treatment for AD
- Medication Has Little Effect on Emotional Blunting in MDD
- Non-Alzheimer Dementia Risk Tied to Physical Activity During Leisure Time
- Naloxone Out-of-Pocket Expenses May Present Barrier for Uninsured
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
Azithromycin in Pediatric Bronchiectasis: What Factors Influence Efficacy?
Myfembree Approved for Management of Endometriosis Pain
Dronedarone Reduces CV Hospitalization, Death in Patients With AF With, Without T2D
COVID-19 Isolation Increased Anxiety and Depression in People With Alzheimer Risk
GAPSS Outperforms QRISK in Assessing Cardiovascular Disease Risk in Patients With SLE
